Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 May;61(5):702–708. doi: 10.1038/bjc.1990.158

The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.

A J Rowland 1, M E Harper 1, D W Wilson 1, K Griffiths 1
PMCID: PMC1971590  PMID: 2337507

Abstract

Methotrexate (MTX) was linked, via an active ester intermediate, to a purified IgG fraction of rabbit polyclonal antiserum raised against a cell membrane preparation from the human prostatic cell line PC3. The resulting conjugates contained an average of 0.044 mg of MTX per mg of antibody with acceptable losses in both the binding activity of the immunoglobulin (27.5%) and the enzyme inhibitory activity of the drug (32% at a MTX concentration of 3 x 10(-7) M). Using cultures of PC3 cells the antibody-MTX (Ab-MTX) conjugates were observed to be as effective as free drug in causing cell death and more effective than non-immune IgG-MTX (NIgG-MTX) conjugates. When athymic nude mice bearing PC3 tumours were administered with Ab-MTX conjugates, significant reductions in tumour growth rates were observed compared to animals given saline, MTX alone or NIgG-MTX conjugates (P less than 0.01 in all cases). Furthermore, the accumulation of radioactive MTX in the tumour tissue of animals injected with these Ab-MTX conjugates was 16-fold greater than those given free drug and 8.6-fold greater than those administered with NIgG-MTX conjugates. Uptake by the reticuloendothelial system, however, was not significantly different when animals from each treatment group were compared.

Full text

PDF
702

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTINO J. R. THE MECHANISM OF ACTION OF THE FOLATE ANTAGONISTS IN MAN. Cancer Res. 1963 Sep;23:1286–1306. [PubMed] [Google Scholar]
  2. Deguchi T., Chu T. M., Leong S. S., Horoszewicz J. S., Lee C. L. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. Cancer Res. 1986 Aug;46(8):3751–3755. [PubMed] [Google Scholar]
  3. Falk L. C., Clark D. R., Kalman S. M., Long T. F. Enzymatic assay for methotrexate in serum and cerebrospinal fluid. Clin Chem. 1976 Jun;22(6):785–788. [PubMed] [Google Scholar]
  4. Fung W. P., Przybylski M., Ringsdorf H., Zaharko D. S. In vitro inhibitory effects of polymer-linked methotrexate derivatives on tetrahydrofolate dehydrogenase and murine L5178Y cells. J Natl Cancer Inst. 1979 May;62(5):1261–1264. [PubMed] [Google Scholar]
  5. Garnett M. C., Embleton M. J., Jacobs E., Baldwin R. W. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro. Int J Cancer. 1983 May 15;31(5):661–670. doi: 10.1002/ijc.2910310520. [DOI] [PubMed] [Google Scholar]
  6. Ghose T., Blair A. H. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. J Natl Cancer Inst. 1978 Sep;61(3):657–676. [PubMed] [Google Scholar]
  7. Ghose T., Guclu A., Faulkner J., Tal J. In vivo suppression of EL 4 lymphomas by rabbit antitumor sera. J Natl Cancer Inst. 1977 Mar;58(3):693–700. doi: 10.1093/jnci/58.3.693. [DOI] [PubMed] [Google Scholar]
  8. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  9. Hurwitz E., Maron R., Bernstein A., Wilchek M., Sela M., Arnon R. The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems. Int J Cancer. 1978 Jun 15;21(6):747–755. doi: 10.1002/ijc.2910210612. [DOI] [PubMed] [Google Scholar]
  10. Johnson J. R., Ford C. H., Newman C. E., Woodhouse C. S., Rowland G. F., Simmonds R. G. A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro. Br J Cancer. 1981 Sep;44(3):472–475. doi: 10.1038/bjc.1981.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kanellos J., Pietersz G. A., Cunningham Z., McKenzie I. F. Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates. Immunol Cell Biol. 1987 Dec;65(Pt 6):483–493. doi: 10.1038/icb.1987.57. [DOI] [PubMed] [Google Scholar]
  12. Kanellos J., Pietersz G. A., McKenzie I. F. Studies of methotrexate-monoclonal antibody conjugates for immunotherapy. J Natl Cancer Inst. 1985 Aug;75(2):319–332. [PubMed] [Google Scholar]
  13. Kulkarni P. N., Blair A. H., Ghose T. I. Covalent binding of methotrexate to immunoglobulins and the effect of antibody-linked drug on tumor growth in vivo. Cancer Res. 1981 Jul;41(7):2700–2706. [PubMed] [Google Scholar]
  14. Kulkarni P. N., Blair A. H., Ghose T., Mammen M. Conjugation of methotrexate to IgG antibodies and their F(ab)2 fragments and the effect of conjugated methotrexate on tumor growth in vivo. Cancer Immunol Immunother. 1985;19(3):211–214. doi: 10.1007/BF00199228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee F. H., Hwang K. M. Antibodies as specific carriers for chemotherapeutic agents. Cancer Chemother Pharmacol. 1979;3(1):17–24. doi: 10.1007/BF00254415. [DOI] [PubMed] [Google Scholar]
  16. Motta R. Passive immunotherapy of leukemia and other cancer. Adv Cancer Res. 1971;14:161–179. doi: 10.1016/s0065-230x(08)60520-5. [DOI] [PubMed] [Google Scholar]
  17. Sibley P. E., Harper M. E., Peeling W. B., Griffiths K. Growth hormone and prostatic tumours: localization using a monoclonal human growth hormone antibody. J Endocrinol. 1984 Dec;103(3):311–315. doi: 10.1677/joe.0.1030311. [DOI] [PubMed] [Google Scholar]
  18. Smyth M. J., Pietersz G. A., Classon B. J., McKenzie I. F. Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies. J Natl Cancer Inst. 1986 Mar;76(3):503–510. [PubMed] [Google Scholar]
  19. Smyth M. J., Pietersz G. A., McKenzie I. F. The mode of action of methotrexate-monoclonal antibody conjugates. Immunol Cell Biol. 1987 Apr;65(Pt 2):189–200. doi: 10.1038/icb.1987.21. [DOI] [PubMed] [Google Scholar]
  20. Sternberger L. A., Hardy P. H., Jr, Cuculis J. J., Meyer H. G. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970 May;18(5):315–333. doi: 10.1177/18.5.315. [DOI] [PubMed] [Google Scholar]
  21. Tai J., Blair A. H., Ghose T. Tumor inhibition by chlorambucil covalently linked to antitumor globulin. Eur J Cancer. 1979 Nov;15(11):1357–1363. doi: 10.1016/0014-2964(79)90112-9. [DOI] [PubMed] [Google Scholar]
  22. Thom D., Powell A. J., Lloyd C. W., Rees D. A. Rapid isolation of plasma membranes in high yield from cultured fibroblasts. Biochem J. 1977 Nov 15;168(2):187–194. doi: 10.1042/bj1680187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tsuruo T., Yamori T., Tsukagoshi S., Sakurai Y. Enhanced cytocidal action of methotrexate by conjugation to concanavalin A. Int J Cancer. 1980 Nov 15;26(5):655–659. doi: 10.1002/ijc.2910260518. [DOI] [PubMed] [Google Scholar]
  24. Uadia P., Blair A. H., Ghose T., Ferrone S. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line. J Natl Cancer Inst. 1985 Jan;74(1):29–35. [PubMed] [Google Scholar]
  25. Vallera D. A., Ash R. C., Zanjani E. D., Kersey J. H., LeBien T. W., Beverley P. C., Neville D. M., Jr, Youle R. J. Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies. Science. 1983 Nov 4;222(4623):512–515. doi: 10.1126/science.6353579. [DOI] [PubMed] [Google Scholar]
  26. WIGZELL H. QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS. Transplantation. 1965 May;3:423–431. doi: 10.1097/00007890-196505000-00011. [DOI] [PubMed] [Google Scholar]
  27. Yang T. J., Vas S. I. Effects of antibodies on L5178Y mouse leukemia cells cultured in vitro. Cancer Res. 1970 May;30(5):1231–1235. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES